REFERENCES
- Ladanyi M, Gorlick R. Molecular pathology and molecular pharmacology of osteosarcoma [review]. Pedriatr Pathol Mol Med. 2000;19:391-413.
- Slominski A,Wortsman J, Carlson A, et al. Molecular pathology of soft tissue and bone tumors [review]. Arch Pathol Lab Med. 1999;123:1246-1259.
- Yokoyama R, SchneiderStork R, Radig K, et al. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas:MDM2amplification and p53 mutations found in progressive tumors. Pathol Res Practice. 1998;194:615-621.